How a Drug Company Made $114 Billion by Gaming the U.S. Patent System

Start

AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.

Previous Story

When Private Equity Came for the Toddler Gyms

Next Story

Johnson & Johnson’s Talc-Related Bankruptcy Filing Is Rejected